Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glutaminergic and Histaminergic Pathway Modulation in Acute Ischemic Stroke as an Effective Neuroprotection Strategy.

NCT02142712 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT02142712
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02142712 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glutaminergic and Histaminergic Pathway Modulation in Acute Ischemic Stroke as an Effective Neuroprotection Strategy.
Lead sponsor
University of Florida
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2014
Completion date
December 31, 2014
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute cerebrovascular accident, cerebral edema